1. Unboosted Atazanavir for Treatment of HIV Infection

   • Emanuele Focà
   • Diego Ripamonti
   • Carlo Torti

   Current Opinion 06 January 2012 Pages: 1161 - 1173

   

2. Overcoming Treatment Resistance in HER2-Positive Breast Cancer

   • Fabio Puglisi
   • Alessandro Marco Minisini
   • Grazia Arpino

   Leading Article 06 January 2012 Pages: 1175 - 1193

   

3. First-Line Disease-Modifying Therapies in Paediatric Multiple Sclerosis

   • Jessica Johnston
   • Tsz-Yin So

   Review Article 06 January 2012 Pages: 1195 - 1211

   

4. Invasive Group A Streptococcal Disease

   • Andrew C. Steer
   • Theresa Lamagni
   • Jonathan R. Carapetis

   Review Article 06 January 2012 Pages: 1213 - 1227

   

5. Mometasone/Formoterol Inhalation Aerosol

   • James E. Frampton

   Adis Drug Profile 06 January 2012 Pages: 1229 - 1241

   

6. Erratum to Mometasone/formoterol inhalation aerosol: in asthma uncontrolled on medium- or high-dose inhaled corticosteroids

   • J. E. Frampton

   Erratum 06 January 2012 Pages: 1242 - 1242

7. Pneumococcal Polysaccharide Conjugate Vaccine (13-Valent, Adsorbed)

   • Mark Sanford

   Adis Drug Profile 06 January 2012 Pages: 1243 - 1255

   

8. Bilastine

   • Natalie J. Carter

   Adis Drug Profile 06 January 2012 Pages: 1257 - 1269

   

9. Apixaban

   • Emma D. Deeks

   Adis Drug Evaluation 06 January 2012 Pages: 1271 - 1291

   

10. Mogamulizumab

    • Joshuan M. Subramaniam
    • Glenn Whiteside
    • Jamie C. Croxtall

    R&D Insight Profile 06 January 2012 Pages: 1293 - 1298

    

11. HIV-1 Antiretroviral Resistance

    • Michele W. Tang
    • Robert W. Shafer

    Review Article Open access 06 January 2012 Pages: e1 - e25